New ways to help people avoid opioid overdose and beat addiction
This is just one example of how Yale School of Medicine researchers and clinicians are pursuing innovations that could both improve treatment of opioid addiction and introduce new painkillers that are effective yet not addictive.Source: Yale Medicine
Yale Triple R: New Initiative and Repository Connecting Research Mentors and Mentees
Traditional Internal Medicine Hospital Resident Saeed Soleymanjahi, MD, MPH started looking for research projects and mentors during the first year of his residency training at Yale, and due to workloads and time constraints, found it challenging to get connected with mentors. Associate Program Director for the Internal Medicine Traditional Residency program Shaili Gupta, MBBS, had been examining ways to make research mentor/mentee connection easier over the last few years.
Improving Heart Bypass Surgery Recovery for Women Takes Innovation and Representation in Research
Twenty years after a study funded by Women's Health Research at Yale uncovered that women face the risk of poorer outcomes after heart bypass surgery, new research finds the increased risk for women persists despite improved overall outcomes. But, with increased representation of women in clinical research and innovation in targets of study, we can overcome the gender gap.
In Memoriam: Robert “Bob” S. Sherwin, MD
Robert “Bob” S. Sherwin, MD, the inaugural director of YCCI, passed away on March 31 at Yale-New Haven Hospital after a long illness. He was 80 years old. Dr. Sherwin, a world-renowned academic diabetologist, led YCCI through a remarkable period of growth, and all of those who worked with him will remember his kindness, guidance, and wisdom. Together they mourn the loss of a leader whose inspiring vision will continue to serve as a beacon for the growth of clinical and translation research at Yale, and beyond, for years to come.
Applying Scientific Research to Our Lives
New medical research findings are published every day, and the results are frequently picked up by mainstream media sources. Before you apply the results of any given study to your daily life, you should consider if the research findings are relevant to you.
YCCI Interim Director, Dr. David Coleman, recipient of the 2023 Larry Zaroff Man of Good Conscious Award
New Interim Director of YCCI David Coleman, MD, Research Professor of Medicine, Emeritus Professor, Yale School of Medicine, is a recipient of the 2023 Larry Zaroff Man of Good Conscious Award from the American Medical Women’s Association. The Association presents this award annually to a man who has been a champion and supporter of women in medicine.
New Data Reported From Trials of Drug Developed at Yale Pathology to Treat Rare, Often Fatal Neonatal Disorder
Clinical trial data from an enzyme-therapy drug developed at Yale Pathology to treat a rare and often fatal neonatal calcification disorder were recently reported. The drug, INZ-701, was designed and validated in the laboratory of Demetrios Braddock, MD, PhD, Associate Professor of Pathology at Yale School of Medicine.
Cracking Peanuts and the Code to Wilson Disease
Warren is the first person in the world to receive a groundbreaking treatment for this rare, serious genetic condition, Wilson Disease, in which excessive amounts of copper accumulates in the body, particularly in the liver and brain. Wilson Disease can cause liver and neurological damage, as well as psychiatric issues with memory, impulse control, and anger. A strong, long-term relationship between Warren and Professor of Medicine Michael Schilsky, MD, the physician who is investigating this treatment, has been essential to this novel treatment which has the potential to help patients all over the world.